Q Therapeutics' Grant

Q Therapeutics raised a round of funding on June 18, 2010. Investors include Maryland Stem Cell Research Fund.

Q Therapeutics, Inc. is developing glial cell-based therapeutic products for central nervous system disorders in which a disease or injury inhibits normal myelin growth and enzyme performance.…

Articles about Q Therapeutics' Grant: